Reticle Biosystems, Inc. filed a Form D with the Securities and Exchange Commission on 2026-07-14.
Reticle Biosystems, Inc. filed a Form D notice of an exempt securities offering with the SEC on July 14, 2026. The filing reports $1M sold. Its industry group is Manufacturing. It names James Che (Executive Officer, Director, Promoter) (SEC Form D, July 14, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Reticle Biosystems, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-07-14 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Reticle Biosystems, Inc.
Free to see. No signup.
More on the people and the money behind Reticle Biosystems, Inc., from the filings we hold.
Manufacturing raises by companies based in California, filed in July 2026, largest first.
Get an email when Reticle Biosystems, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Reticle Biosystems, Inc. raises, hires or launches. No email unless you switch it on.
Watch Reticle Biosystems, Inc. →Get the full cited report on Reticle Biosystems, Inc.
What the filing shows about Reticle Biosystems, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Reticle Biosystems, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Reticle Biosystems, Inc.'s address as 2261 Market Street Ste 78326, San Francisco, CA 94114.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Reticle Biosystems, Inc. See pricing
Reticle Biosystems, Inc. is a registered filer with the SEC (CIK 2144345) and has filed since 2026-07-14. 1 filing is on record, the latest on 2026-07-14.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Reticle Biosystems, Inc.'s Form D of 2026-07-14 names James Che as its officers, directors or promoters.
Its new offerings report $1M sold across 1 offering, as its own filings state.
Trailing twelve months. 370 filings in Manufacturing, totalled by week. The dot is this raise, $1M, on the same scale — one filing against the whole group's total, so it sits low by construction.
The proceeds of the offering will be used for general working capital purposes, which may include the payment of salaries to executive officers in the ordinary course of business.
James Che is named as Executive Officer and Director and Promoter on the Form D that Reticle Biosystems, Inc. filed with the SEC on 14 July 2026, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2026-07-14 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about Reticle Biosystems, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Reticle Biosystems, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Reticle Biosystems, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Reticle Biosystems, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Reticle Biosystems, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Reticle Biosystems, Inc.. With no account yet, you sign up free and land on the result.
On these lists: San Francisco Bay Area raises, week of 2026-07-13 · Manufacturing raises, week of 2026-07-13 · Manufacturing raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/reticle-biosystems-inc-form-d-26000001